Reports Q3 revenue $20.69M, consensus $21.78M. “We demonstrated continued growth and meaningful progress this quarter, resulting from a strengthened leadership team and strategic changes to enhance our commercial organization,” said Antony Koblish, co-founder and CEO.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TELA:
- TELA Earnings this Week: How Will it Perform?
- TELA Bio Appoints William Plovanic to Board
- Tela Bio’s OviTex PRS Study: A New Frontier in Breast Reconstruction
- Tela Bio’s OviTex Study: A Potential Game-Changer in Hernia Repair
- Tela Bio’s OviTex Study: A Potential Game-Changer for Hiatal Hernia Treatment